Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE

Antonio Hernández-Madrid; Thomas Paul; Dominic Abrams; Peter F. Aziz; Nico A. Blom; Jian Chen; Massimo Chessa; Nicolas Combes; Nikolaos Dagres; Gerhard Diller; Sabine Ernst; Alessandro Giamberti; Joachim Hebe; Jan Janousek; Thomas Kriebel; Jose Moltedo; Javier Moreno; Rafael Peinado; Laurent Pison; Eric Rosenthal; Jonathan R. Skinner; Katja Zeppenfeld; Christian Sticherling; Joseph Kautzner; Erik Wissner; Philipp Sommer; Dhiraj Gupta; Tamas Szili-Torok; Shigeru Tateno; Armando Alfaro; Werner Budts; Pastora Gallego; Markus Schwerzmann; Ornella Milanesi; Georgia Sarquella-Brugada; Laszlo Kornyei; Narayanswami Sreeram; Fabrizio Drago; Anne Dubin

doi:10.1093/europace/eux380

Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE

Antonio Hernández-Madrid
, Thomas Paul
, Dominic Abrams
, Peter F. Aziz
, Nico A. Blom
, Jian Chen
, Massimo Chessa
, Nicolas Combes
, Nikolaos Dagres
, Gerhard Diller
, Sabine Ernst
, Alessandro Giamberti
, Joachim Hebe
, Jan Janousek
, Thomas Kriebel
, Jose Moltedo
, Javier Moreno
, Rafael Peinado
, Laurent Pison
, Eric Rosenthal

Jonathan R. Skinner, Katja Zeppenfeld, Christian Sticherling, Joseph Kautzner, Erik Wissner, Philipp Sommer, Dhiraj Gupta, Tamas Szili-Torok, Shigeru Tateno, Armando Alfaro, Werner Budts, Pastora Gallego, Markus Schwerzmann, Ornella Milanesi, Georgia Sarquella-Brugada, Laszlo Kornyei, Narayanswami Sreeram, Fabrizio Drago, Anne Dubin

University of Alcalá
University of Göttingen
Boston Children's Hospital
Cleveland Clinic Foundation
Leiden University
Amsterdam UMC - University of Amsterdam
University of Bergen
IRCCS Policlinico San Donato
Clinique Pasteur Toulouse
Fresenius AG
University of Münster
Royal Brompton and Harefield NHS Foundation Trust
Heart Center Bremen
Charles University
Department of Paediatrics and Paediatric Cardiology
Section of Pediatric Cardiology Clinica y Maternidad Suizo Argentina
University Hospital La Paz Madrid
Maastricht University
Department of Basic and Clinical Neuroscience
Paediatric and Congenital Cardiac Services Starship Children's Hospital
University of Basel
Institute for Clinical and Experimental Medicine
University of Illinois Chicago
University of Liverpool
Erasmus University Rotterdam
Chiba Cerebral and Cardiovascular Center
Hospital La Católica
KU Leuven
Hospital Universitario Virgen Macarena
University of Bern
University of Padua
University of Barcelona
Pediatric
University of Cologne
IRCCS Ospedale pediatrico Bambino Gesù - Roma
Division of Pediatric Cardiology

Research output: Contribution to journal › Article › peer-review

Abstract

The population of patients with congenital heart disease (CHD) is continuously increasing with more and more patients reaching adulthood. A significant portion of these young adults will suffer from arrhythmias due to the underlying congenital heart defect itself or as a sequela of interventional or surgical treatment. The medical community will encounter an increasing challenge as even most of the individuals with complex congenital heart defects nowadays become young adults. Within the past 20 years, management of patients with arrhythmias has gained remarkable progress including pharmacological treatment, catheter ablation, and device therapy. Catheter ablation in patients with CHD has paralleled the advances of this technology in pediatric and adult patients with structurally normal hearts. Growing experience and introduction of new techniques like the 3D mapping systems into clinical practice have been particularly beneficial for this growing population of patients with abnormal cardiac anatomy and physiology. Finally, device therapies allowing maintanence of chronotropic competence and AV conduction, improving haemodynamics by cardiac resynchronization, and preventing sudden death are increasingly used. For pharmacological therapy, ablation procedures, and device therapy decision making requires a deep understanding of the individual pathological anatomy and physiology as well as detailed knowledge on natural history and long-term prognosis of our patients. Composing expert opinions from cardiology and paediatric cardiology as well as from non-invasive and invasive electrophysiology this position paper was designed to state the art in management of young individuals with congenital heart defects and arrhythmias.

Original language	English
Pages (from-to)	1719-1720
Number of pages	2
Journal	Europace
Volume	20
Issue number	11
DOIs	https://doi.org/10.1093/europace/eux380
Publication status	Published - 1 Nov 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Ablation
Arrhythmia
Atrioventricular block
Bradycardia
Cardiac resynchronization therapy
Congenital heart disease
European Heart Rhythm Association position paper
Heart failure
Implantable cardioverter-defibrillator
Macroreentry tachycardia
Pacemaker
Sudden cardiac death

Access to Document

10.1093/europace/eux380

Fingerprint

Dive into the research topics of 'Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE'. Together they form a unique fingerprint.

Cite this

Hernández-Madrid, A., Paul, T., Abrams, D., Aziz, P. F., Blom, N. A., Chen, J., Chessa, M., Combes, N., Dagres, N., Diller, G., Ernst, S., Giamberti, A., Hebe, J., Janousek, J., Kriebel, T., Moltedo, J., Moreno, J., Peinado, R., Pison, L., ... Dubin, A. (2018). Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace, 20(11), 1719-1720. https://doi.org/10.1093/europace/eux380

Hernández-Madrid, Antonio ; Paul, Thomas ; Abrams, Dominic et al. / Arrhythmias in congenital heart disease : A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. In: Europace. 2018 ; Vol. 20, No. 11. pp. 1719-1720.

@article{fe57a07ccd3e4473ae663918bc2484c7,

title = "Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE",

abstract = "The population of patients with congenital heart disease (CHD) is continuously increasing with more and more patients reaching adulthood. A significant portion of these young adults will suffer from arrhythmias due to the underlying congenital heart defect itself or as a sequela of interventional or surgical treatment. The medical community will encounter an increasing challenge as even most of the individuals with complex congenital heart defects nowadays become young adults. Within the past 20 years, management of patients with arrhythmias has gained remarkable progress including pharmacological treatment, catheter ablation, and device therapy. Catheter ablation in patients with CHD has paralleled the advances of this technology in pediatric and adult patients with structurally normal hearts. Growing experience and introduction of new techniques like the 3D mapping systems into clinical practice have been particularly beneficial for this growing population of patients with abnormal cardiac anatomy and physiology. Finally, device therapies allowing maintanence of chronotropic competence and AV conduction, improving haemodynamics by cardiac resynchronization, and preventing sudden death are increasingly used. For pharmacological therapy, ablation procedures, and device therapy decision making requires a deep understanding of the individual pathological anatomy and physiology as well as detailed knowledge on natural history and long-term prognosis of our patients. Composing expert opinions from cardiology and paediatric cardiology as well as from non-invasive and invasive electrophysiology this position paper was designed to state the art in management of young individuals with congenital heart defects and arrhythmias.",

keywords = "Ablation, Arrhythmia, Atrioventricular block, Bradycardia, Cardiac resynchronization therapy, Congenital heart disease, European Heart Rhythm Association position paper, Heart failure, Implantable cardioverter-defibrillator, Macroreentry tachycardia, Pacemaker, Sudden cardiac death",

author = "Antonio Hern{\'a}ndez-Madrid and Thomas Paul and Dominic Abrams and Aziz, \{Peter F.\} and Blom, \{Nico A.\} and Jian Chen and Massimo Chessa and Nicolas Combes and Nikolaos Dagres and Gerhard Diller and Sabine Ernst and Alessandro Giamberti and Joachim Hebe and Jan Janousek and Thomas Kriebel and Jose Moltedo and Javier Moreno and Rafael Peinado and Laurent Pison and Eric Rosenthal and Skinner, \{Jonathan R.\} and Katja Zeppenfeld and Christian Sticherling and Joseph Kautzner and Erik Wissner and Philipp Sommer and Dhiraj Gupta and Tamas Szili-Torok and Shigeru Tateno and Armando Alfaro and Werner Budts and Pastora Gallego and Markus Schwerzmann and Ornella Milanesi and Georgia Sarquella-Brugada and Laszlo Kornyei and Narayanswami Sreeram and Fabrizio Drago and Anne Dubin",

note = "Publisher Copyright: {\textcopyright} 2017 The Author(s).",

year = "2018",

month = nov,

day = "1",

doi = "10.1093/europace/eux380",

language = "English",

volume = "20",

pages = "1719--1720",

journal = "Europace",

issn = "1099-5129",

number = "11",

}

Hernández-Madrid, A, Paul, T, Abrams, D, Aziz, PF, Blom, NA, Chen, J, Chessa, M, Combes, N, Dagres, N, Diller, G, Ernst, S, Giamberti, A, Hebe, J, Janousek, J, Kriebel, T, Moltedo, J, Moreno, J, Peinado, R, Pison, L, Rosenthal, E, Skinner, JR, Zeppenfeld, K, Sticherling, C, Kautzner, J, Wissner, E, Sommer, P, Gupta, D, Szili-Torok, T, Tateno, S, Alfaro, A, Budts, W, Gallego, P, Schwerzmann, M, Milanesi, O, Sarquella-Brugada, G, Kornyei, L, Sreeram, N, Drago, F & Dubin, A 2018, 'Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE', Europace, vol. 20, no. 11, pp. 1719-1720. https://doi.org/10.1093/europace/eux380

Arrhythmias in congenital heart disease: A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. / Hernández-Madrid, Antonio; Paul, Thomas; Abrams, Dominic et al.
In: Europace, Vol. 20, No. 11, 01.11.2018, p. 1719-1720.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Arrhythmias in congenital heart disease

T2 - A position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE

AU - Hernández-Madrid, Antonio

AU - Paul, Thomas

AU - Abrams, Dominic

AU - Aziz, Peter F.

AU - Blom, Nico A.

AU - Chen, Jian

AU - Chessa, Massimo

AU - Combes, Nicolas

AU - Dagres, Nikolaos

AU - Diller, Gerhard

AU - Ernst, Sabine

AU - Giamberti, Alessandro

AU - Hebe, Joachim

AU - Janousek, Jan

AU - Kriebel, Thomas

AU - Moltedo, Jose

AU - Moreno, Javier

AU - Peinado, Rafael

AU - Pison, Laurent

AU - Rosenthal, Eric

AU - Skinner, Jonathan R.

AU - Zeppenfeld, Katja

AU - Sticherling, Christian

AU - Kautzner, Joseph

AU - Wissner, Erik

AU - Sommer, Philipp

AU - Gupta, Dhiraj

AU - Szili-Torok, Tamas

AU - Tateno, Shigeru

AU - Alfaro, Armando

AU - Budts, Werner

AU - Gallego, Pastora

AU - Schwerzmann, Markus

AU - Milanesi, Ornella

AU - Sarquella-Brugada, Georgia

AU - Kornyei, Laszlo

AU - Sreeram, Narayanswami

AU - Drago, Fabrizio

AU - Dubin, Anne

PY - 2018/11/1

Y1 - 2018/11/1

N2 - The population of patients with congenital heart disease (CHD) is continuously increasing with more and more patients reaching adulthood. A significant portion of these young adults will suffer from arrhythmias due to the underlying congenital heart defect itself or as a sequela of interventional or surgical treatment. The medical community will encounter an increasing challenge as even most of the individuals with complex congenital heart defects nowadays become young adults. Within the past 20 years, management of patients with arrhythmias has gained remarkable progress including pharmacological treatment, catheter ablation, and device therapy. Catheter ablation in patients with CHD has paralleled the advances of this technology in pediatric and adult patients with structurally normal hearts. Growing experience and introduction of new techniques like the 3D mapping systems into clinical practice have been particularly beneficial for this growing population of patients with abnormal cardiac anatomy and physiology. Finally, device therapies allowing maintanence of chronotropic competence and AV conduction, improving haemodynamics by cardiac resynchronization, and preventing sudden death are increasingly used. For pharmacological therapy, ablation procedures, and device therapy decision making requires a deep understanding of the individual pathological anatomy and physiology as well as detailed knowledge on natural history and long-term prognosis of our patients. Composing expert opinions from cardiology and paediatric cardiology as well as from non-invasive and invasive electrophysiology this position paper was designed to state the art in management of young individuals with congenital heart defects and arrhythmias.

AB - The population of patients with congenital heart disease (CHD) is continuously increasing with more and more patients reaching adulthood. A significant portion of these young adults will suffer from arrhythmias due to the underlying congenital heart defect itself or as a sequela of interventional or surgical treatment. The medical community will encounter an increasing challenge as even most of the individuals with complex congenital heart defects nowadays become young adults. Within the past 20 years, management of patients with arrhythmias has gained remarkable progress including pharmacological treatment, catheter ablation, and device therapy. Catheter ablation in patients with CHD has paralleled the advances of this technology in pediatric and adult patients with structurally normal hearts. Growing experience and introduction of new techniques like the 3D mapping systems into clinical practice have been particularly beneficial for this growing population of patients with abnormal cardiac anatomy and physiology. Finally, device therapies allowing maintanence of chronotropic competence and AV conduction, improving haemodynamics by cardiac resynchronization, and preventing sudden death are increasingly used. For pharmacological therapy, ablation procedures, and device therapy decision making requires a deep understanding of the individual pathological anatomy and physiology as well as detailed knowledge on natural history and long-term prognosis of our patients. Composing expert opinions from cardiology and paediatric cardiology as well as from non-invasive and invasive electrophysiology this position paper was designed to state the art in management of young individuals with congenital heart defects and arrhythmias.

KW - Ablation

KW - Arrhythmia

KW - Atrioventricular block

KW - Bradycardia

KW - Cardiac resynchronization therapy

KW - Congenital heart disease

KW - European Heart Rhythm Association position paper

KW - Heart failure

KW - Implantable cardioverter-defibrillator

KW - Macroreentry tachycardia

KW - Pacemaker

KW - Sudden cardiac death

UR - https://www.scopus.com/pages/publications/85053341987

U2 - 10.1093/europace/eux380

DO - 10.1093/europace/eux380

M3 - Article

C2 - 29579186

AN - SCOPUS:85053341987

SN - 1099-5129

VL - 20

SP - 1719

EP - 1720

JO - Europace

JF - Europace

IS - 11

ER -